Loading...
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
The immunotherapeutic agent ipilimumab has helped address a significant unmet need in the treatment of advanced melanoma. Ipilimumab is a fully human monoclonal antibody that targets cytotoxic T-lymphocyte antigen-4 (CTLA-4), thereby augmenting antitumor immune responses. After decades in which a nu...
Na minha lista:
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Wiley Periodicals Inc.
2013
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3910157/ https://ncbi.nlm.nih.gov/pubmed/23772560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/nyas.12180 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|